Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 958 to 1007 of 3730 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
480\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6428\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6396.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00488\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
481\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 5 (ec 2.7.1.-) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5) (apoptosis signal- regulating kinase 1) (ask-1). [source:swissprot;acc:q99683]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
565.785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
563.113\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00475\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
482\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
793.778\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
796.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00387\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
483\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20612.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20672.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0029\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
484\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
958.429\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
961.098\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00278\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
485\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high mobility group protein 4-like (hmg-4l). [source:swissprot;acc:q9uj13]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
22850.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22797.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00229\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
486\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear autoantigen sp-100 (speckled 100 kda) (nuclear dot-associated sp100 protein) (lysp100b). [source:swissprot;acc:p23497]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22878.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22826.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00227\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
10908.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12491.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14513\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
487\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5277.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6042.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14505\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
249.857\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00225\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
488\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10872.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12447\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14483\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
249.857\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00225\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
489\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj579f20.1 (high-mobility group (nonhistone chromosomal) protein 1-like 1). [source:sptrembl;acc:q9nqj4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
22946.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22895.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00224\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5281.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6044.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14457\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
490\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high mobility group protein 1-like 10 (hmg-1l10). [source:swissprot;acc:q9ugv6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22940.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22888.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00224\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15274.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13346.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14445\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
491\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high mobility group protein 1 (hmg-1). [source:swissprot;acc:p09429]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22962\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22910.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00223\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5980.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6843.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14437\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
492\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase (fragments). [source:sptrembl;acc:q9udk8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5038.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5046.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00159\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5979.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6842.76\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14429\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
493\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5979.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6842.78\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2410.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2411.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00059\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
494\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
e2a-pbx1-associated protein; putative 47 kda protein. [source:refseq;acc:nm\_020140]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5979.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6842.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14428\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2a.c/d/i/n/p (h2a.1) (h2a/c) (h2a/d) (h2a/i) (h2a/n) (h2a/p) (h2a.1b). [source:swissprot;acc:p02261]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
495\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2a.a (h2a/a) (h2a.2). [source:swissprot;acc:p28001]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tetranectin precursor (tn) (plasminogen-kringle 4 binding protein). [source:swissprot;acc:p05452]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10804.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12363.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14428\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
496\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s6 (mrp-s6). [source:swissprot;acc:p82932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nostrin. [source:refseq;acc:nm\_052946]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
497\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eap30 subunit of ell complex. [source:refseq;acc:nm\_007241]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2a; h2a histone family, member r. [source:refseq;acc:nm\_170745]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
498\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
liv-1 protein, estrogen regulated. [source:refseq;acc:nm\_012319]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translin-associated protein x (translin-associated factor x). [source:swissprot;acc:q99598]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
499\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homogentisate 1,2-dioxygenase (ec 1.13.11.5) (homogentisicase) (homogentisate oxygenase) (homogentisic acid oxidase). [source:swissprot;acc:q93099]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
500\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rwd domain containing 1; ptd013 protein; cgi-24 protein. [source:refseq;acc:nm\_015952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
501\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate decarboxylase, 67 kda isoform (ec 4.1.1.15) (gad-67) (67 kda glutamic acid decarboxylase). [source:swissprot;acc:q99259]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
h2a histone family, member j isoform 1. [source:refseq;acc:nm\_018267]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
502\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca1 associated protein. [source:refseq;acc:nm\_006768]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m1 chain (ec 1.17.4.1) (ribonucleotide reductase large chain). [source:swissprot;acc:p23921]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6913.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7907.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1437\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor suppressor p53-binding protein 2 (p53-binding protein 2) (53bp2) (bcl2-binding protein) (bbp). [source:swissprot;acc:q13625]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
15182.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13277.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14344\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enoyl-coa hydratase, mitochondrial precursor (ec 4.2.1.17) (short chain enoyl-coa hydratase) (sceh) (enoyl-coa hydratase 1). [source:swissprot;acc:p30084]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10067.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14334\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transduction protein cbl-b (sh3-binding protein cbl-b). [source:swissprot;acc:q13191]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6856.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7838.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14316\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/